Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Active not recruiting 8Terminated 5Recruiting 5Completed 5Withdrawn 3

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Breast 1

Conditions

Sarcoma, Kaposi 1HIV Infections 1Breast Neoplasms 1Advanced Solid Tumors 1AIDS-related Kaposi sarcoma 1

Interventions

Cyclophosphamide 128Cisplatin 119Radiotherapy 111pembrolizumab 110Paclitaxel 96Gemcitabine 96Carboplatin 96Nivolumab 76Magnetic Resonance Spectroscopy 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Doxorubicin 52fludarabine 51Biopsy 48durvalumab 44Cytarabine 44Drug Therapy 43Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Lenalidomide 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Interventional × nirogacestat × Clear all
NCT02338531 2016-04-29

RHEA

Jules Bordet Institute

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT02462707 2015-10-07

A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors

Pfizer

Phase 1 Withdrawn
Other solid neoplasm

Advanced Solid Tumors

NCT02137564 2015-07-23

Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡